InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Explore the detailed record of transactions filed by LEVINE JOSHUA, Chief Executive Officer. Insider active across 2 companies, notably Natus Medical INC. Cumulatively, 11 reports have been published. Total volume traded: €269k. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
05,075 shares0
Common Stock, $0.001 par value per share
SEC:0000878526-22-000047:0·
0250,501 shares0
Common Stock
SEC:0001214659-21-011053·
0250,501 shares0
Common Stock
SEC:0001214659-21-011053:0·
€53,85515,741 shares@ €3.421340.0% of flow
Common Stock
SEC:0001214659-21-010427·
€53,85515,741 shares@ €3.42130.17% mcap20.0% of flow
Common Stock
SEC:0001214659-21-010427:0·
€53,85515,741 shares@ €3.421340.0% of flow
Common Stock
SEC:0001214659-21-010202·
€53,85515,741 shares@ €3.42130.17% mcap20.0% of flow
Common Stock
SEC:0001214659-21-010202:0·
€26,9238,680 shares@ €3.101720.0% of flow
Common Stock
SEC:0001214659-21-008821·
Ideal exit: 15 May 2022 (T+270)
€26,9238,680 shares@ €3.10170.084% mcap10.0% of flow
Common Stock
SEC:0001214659-21-008821:0·
Ideal exit: 15 May 2022 (T+270)
€125,9145,214 shares@ €24.1492100.0% of flow
Common Stock, $0.001 par value per share
SEC:0000878526-21-000067·
€125,9145,214 shares@ €24.149250.0% of flow
Common Stock, $0.001 par value per share
SEC:0000878526-21-000067:0·
11 of 11 declarations
About LEVINE JOSHUA
Joshua Levine is the CEO and Director of NATUS MEDICAL INC and ACCURAY INC. As a leader, he is responsible for the strategic and operational direction of these companies. His expertise in the medical sector and ability to lead teams enable him to drive innovation and growth. He plays a key role in business development and stakeholder engagement.
